The association between insulin resistance and DRs has been demonstrated in liver disorders including NASH and chronic hepatitis C [32,34], in which defective IRS2 expression has also been reported [10,11]. Here, IRS2 is linked to metabolic dysfunction-associated steatohepatitis.